ArticleBMC psychiatry2025
Alcohol-induced psychosis and delirium tremens: a comparison with alcohol dependence on demographic characteristics, mortality, and morbidity.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Romanian male patients with the dual diagnosis of schizophrenia and alcohol use disorder: a prospective study of clinical, social, and treatment-related factors affecting quality of life.Frontiers in psychiatry · 2026Article
- Clinical study on auricular point pressing beans combined with quetiapine in the treatment of alcohol-induced psychotic disorders.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe study aim was to compare patients with alcohol-induced psychosis (AIP) and delirium tremens (DT) with patients with alcohol dependency (AD) only. Using data from Norwegian Patient Registry (NPR) we investigated demographic characteristics, mortality, and physical and mental health comorbidities, among individuals with AIP or DT compared with AD patients.
methodsData from NPR was used to create a cohort of patients aged 20-79 diagnosed with either AIP, DT or AD, from 2009 to 2015. If patients received more than one of these diagnoses, AIP and DT were prioritized. For patients with both AIP and DT, the earliest diagnosis took priority, except when the diagnoses were assigned simultaneously, when DT was prioritized. Data on comorbidities were taken from NPR, while cause of death was obtained from the Norwegian Cause of Death Registry. Estimates were compared using chi-square test and the Kruskal-Wallis test with Bonferroni adjustments for multiple testing. Mortality was analysed using Cox regression models and by calculating standardized mortality ratios, adjusting for age and gender.
resultsThe cohort included 33 107 patients diagnosed with AD, 1 784 with DT, and 700 with AIP. AIP patients were the youngest. DT patients displayed significantly higher mortality rates, with an annual rate of 8.0%, and generally increased comorbidity rates. AIP patients showed significantly higher rates of schizophrenia spectrum disorders compared to both AD and DT patients, highlighting a potential link between AIP and psychotic disorders.
conclusionThis study reveals that patients with DT experience higher morbidity and mortality rates compared to those with AIP and AD. AIP patients did not show increased all-cause or cause-specific mortality compared to AD patients across a variety of causes. Notably, AIP seemed to be more closely linked to comorbid schizophrenia spectrum disorders than AD and DT patients. The findings underscore the complexities of AIP in relation to schizophrenia and highlight significant differences in health outcomes among the three patient groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.